Biopharmaceutical News and Research

RSS

Sartorius launches BIOSTAT RM TX single-use bioreactor for consistent quality cellular products

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of the BIOSTAT RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.

From Sartorius 22 Jan 2019

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

From Charles River 16 Jan 2019

Scientists develop monoclonal antibodies combinations that protect animals from Ebola viruses

Scientists from academia, industry, and government have developed a combination of monoclonal antibodies that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe.

11 Jan 2019

Experimental drug can protect against Ebola in a single dose

There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. The findings are now available in Cell Host & Microbe.

9 Jan 2019

Scientists highlight lack of diversity in genomic studies

A growing number of genomic studies have generated important discoveries regarding human health and behavior, but new research from the University of Oxford suggests that scientific advancement is limited by a lack of diversity.

7 Jan 2019

Envigo expands its bioanalytical capabilities in response to increased market demand

Envigo, a leading provider of nonclinical contract research services and research models, has invested in an expansion of its global bioanalytical capabilities in response to increased market demand from its biopharmaceutical customers.

From Inotiv, Inc. 3 Jan 2019

Alzheimer’s Disease: Learning from the Past, Looking to the Future

An interview with Dr. Lloyd Tran, discussing the major barriers to Alzheimer’s research and development over the past 40 years.

From Alzheimer International Society 3 Jan 2019

ERADA launches first diagnostic saliva test for malaria

ERADA Technology Alliance Ltd, pioneers of innovative, rapid diagnostic solutions for early detection of infectious diseases, have announced the imminent launch of a world first diagnostic saliva test for malaria.

2 Jan 2019

Lupin partners with Abbvie to develop and commercialize new targeted oncology treatments

Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.

25 Dec 2018

Study may identify new diagnostics and treatment option for CVD

Forty-two percent of all deaths in the United States are related to cardiovascular disease. According to the Global Cardiovascular Drugs Market Forecast, by 2030 the number of deaths from CVD will rise to 23.6 million per year in the U.S. alone.

19 Dec 2018

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Dr. John McCafferty celebrates the success of phage display technology with Nobel Prize in Chemistry Laureates.

From FairJourney Biologics 12 Dec 2018

New therapeutic strategy is emerging for type 2 diabetes

Diabetes is a disease in which blood sugar levels are high over a prolonged period (hyperglycemia). In the case of type 2 diabetes, this phenomenon which is caused by a disruption of the glucose metabolism develops progressively and insidiously.

6 Dec 2018

Governments across Europe respond in very different ways to lung cancer

The World Health Organization estimates 387,913 Europeans will die of lung cancer in 2018. The preliminary findings from a new study by the Economist Intelligence Unit comparing 13 countries show that governments across Europe are responding in very different ways to the disease.

4 Dec 2018

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, have partnered to develop nanoantibodies for therapeutic applications.

3 Dec 2018

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Sartorius Stedim Biotech, a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals, announced today that both parties have entered into a collaboration.

3 Dec 2018

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the "2018 Shunde Biomedical Industry Investment Promotion Conference" which ran in parallel with the Precision Medicine and Ion Channel Retreat was successfully held at the Ramada Plaza Hotel, Shunde, Guang Dong, China.

3 Dec 2018

Insights from the Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the 2018 Shunde Biomedical Industry Investment Promotion Conference was successfully held at the Ramada Plaza Hotel, Shunde, GuangDong, China

From Aurora Biomed Inc. 29 Nov 2018

Using Pre-Clinical Imaging to Detect Cancer

In this interview, Émilie Beaulieu Ouellet, Application Scientist for life science imaging at Photon Etc talks to New-Medical about their range of preclinical infrared imagers and how they can allow cancer detection.

From Photon etc. 27 Nov 2018

Report shows strong but uneven spending in medical and health R&D over five-year period in the U.S.

Total U.S. investment in medical and health research and development in the U.S. grew by 27% over the five-year period from 2013 to 2017, led by industry and the federal government, according to U.S. Investments in Medical and Health Research and Development, a new report from Research!America.

21 Nov 2018

Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration

In January 2009, the life of engineer Michel Meunier, a professor at Polytechnique Montréal, changed dramatically. Like others, he had observed that the extremely short pulse of a femtosecond laser (0.000000000000001 second) could make nanometer-sized holes appear in silicon when it was covered by gold nanoparticles.

20 Nov 2018

Biopharmaceutical News and Research

Sartorius launches BIOSTAT RM TX single-use bioreactor for consistent quality cellular products

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Scientists develop monoclonal antibodies combinations that protect animals from Ebola viruses

Experimental drug can protect against Ebola in a single dose

Scientists highlight lack of diversity in genomic studies

Envigo expands its bioanalytical capabilities in response to increased market demand

Alzheimer’s Disease: Learning from the Past, Looking to the Future

ERADA launches first diagnostic saliva test for malaria

Lupin partners with Abbvie to develop and commercialize new targeted oncology treatments

Study may identify new diagnostics and treatment option for CVD

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

New therapeutic strategy is emerging for type 2 diabetes

Governments across Europe respond in very different ways to lung cancer

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

Insights from the Shunde Biomedical Industry Investment Promotion Conference

Using Pre-Clinical Imaging to Detect Cancer

Report shows strong but uneven spending in medical and health R&D over five-year period in the U.S.

Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration

Biotechnology eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News